Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Return to work following meningioma surgery: a Swedish nationwide registry-based matched cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Shared decision making in high-grade glioma patients—a systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Neurosurgical patterns of care for diffuse low-grade gliomas in Sweden between 2005 and 2015

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Long-Term Follow-Up and Predictors of Functional Outcome after Surgery for Spinal Meningiomas: A Population-Based Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Risk factors for need of reoperation in bilateral chronic subdural haematomas

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Development and external validation of a clinical prediction model for functional impairment after intracranial tumor surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Erik Thurin
  • Alba Corell
  • Sasha Gulati
  • Anja Smits
  • Roger Henriksson
  • J Bartek
  • Øyvind Salvesen
  • Asgeir Store Jakola
Vis graf over relationer

Background: Meningioma is the most common primary intracranial tumor. It is usually slow growing and benign, and surgery is the main treatment modality. There are limited data on return to work following meningioma surgery. The objective of this study was to determine the patterns of sick-leave rate prior to surgery, and up to 2 years after, in patients compared to matched controls. Methods: Data on patients ages 18 to 60 years with histologically verified intracranial meningioma between 2009 and 2015 were identified in the Swedish Brain Tumor Registry (SBTR) and linked to 3 national registries after 5 matched controls were assigned to each patient. Results: We analyzed 956 patients and 4765 controls. One year prior to surgery, 79% of meningioma patients and 86% of controls were working (P <. 001). The proportion of patients at work 2 years after surgery was 57%, in contrast to 84% of controls (P <. 001). Statistically significant negative predictors for return to work in patients 2 years after surgery were high (vs low) tumor grade, previous history of depression, amount of sick leave in the year preceding surgery, and surgically acquired neurological deficits. Conclusion: There is a considerable risk for long term sick leave 2 years after meningioma surgery. Neurological impairment following surgery was a modifiable risk factor increasing the risk for long-term sick leave. More effective treatment of depression may facilitate return to work in this patient group.

OriginalsprogEngelsk
TidsskriftNeuro-Oncology Practice
Vol/bind7
Udgave nummer3
Sider (fra-til)320-328
Antal sider9
ISSN2054-2577
DOI
StatusUdgivet - jun. 2020

Bibliografisk note

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

ID: 61631534